# Center Ventures

> Center Ventures is a VC fund in Taipei backing Biotechnology and Pharmaceutical. See 7 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Location: Taipei, Taiwan
- Total investments: 7
- Last investment: Mar 2025
- Lead investor: 29%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/center-ventures/
- Website: https://www.centerlab.com.tw
- Facebook: https://www.facebook.com/people/%E6%99%9F%E5%BE%B7%E5%A4%A7%E8%97%A5%E5%BB%A0%E8%82%A1%E4%BB%BD%E6%9C%89%E9%99%90%E5%85%AC%E5%8F%B8/100066951346620/

Center Ventures is a VC fund in Taipei focused on Biotechnology and Pharmaceutical. Founded as a pharmaceutical company, they are equipped with practical experience and business expertise in biotechnology. Their familiarity with the industry value chain and ecosystem, along with complete expert network and resource integration capabilities, make us the most professional biotechnology incubator platform in Asia Pacific.

## Round sizes

| Stage | Round size |
| --- | --- |
| Series A | $24M–$62M |
| Series B | $100M–$102M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biotechnology | 4 | 57% |
| Pharmaceutical | 3 | 43% |
| Medical | 2 | 29% |
| Biopharma | 2 | 29% |
| Genetics | 1 | 14% |

10 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 2 | 29% |
| Series B | 2 | 29% |
| Seed | 1 | 14% |
| Series C | 1 | 14% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| China | 4 | 57% |
| Taiwan | 1 | 14% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Hipot | Hipot is a technological innovation company dedicated to providing hydrogen fuel cell commercial vehicle transportation solutions. | $62M | Series A | Mar 24, 2025 |  |
| Baoji Pharmaceutical | Baoji Pharmaceutical is a biopharma R&D manufacturer, a Sino-foreign joint biopharmaceutical enterprise integrating drug R&D and production. |  | Series C | Dec 01, 2024 |  |
| Baoji Pharmaceutical | Baoji Pharmaceutical is a biopharma R&D manufacturer, a Sino-foreign joint biopharmaceutical enterprise integrating drug R&D and production. |  | Series C | Jul 19, 2024 |  |
| GenEditBio | GenEditBio is a biotech company that specializes in providing curative gene editing based solutions for genetic diseases. | $90M | Seed | Apr 04, 2024 |  |
| Baoji Pharmaceutical | Baoji Pharmaceutical is a biopharma R&D manufacturer, a Sino-foreign joint biopharmaceutical enterprise integrating drug R&D and production. | $100M | Series B | Aug 26, 2022 |  |
| Immunwork | Immunwork develops innovative drugs that combine targeting and effector functions to enhance efficacy and safety. The company focuses on creating ultralong-acting analogues, such as TE-8214, an octreotide derivative, and TE-8035, a modified human insulin. Immunwork's drug pipeline addresses immune system diseases and leverages a proprietarytechnology platform. The company is involved in clinical trials to validate its therapeutic solutions. | $23.7M | Series A | Mar 08, 2022 |  |
| TOT BIOPHARM | TOT BIOPHARM is a clinical-stage biopharmaceutical company dedicated to developing and commercializing innovative oncology drugs and therapies. Our mission is to build a leading brand name of oncology treatments trusted by patients and their families as well as medical professionals in China. | $102M | Series B | Aug 08, 2018 |  |

7 of 7 investments shown.

## Co-investors
- [Finnova Capital](https://shizune.co/investors/profile/finnova-capital) — VC Fund, 2 deals together
- [Qiming Venture Partners](https://shizune.co/investors/profile/qiming-venture-partners) — VC Fund, 2 deals together
- [99Fund](https://shizune.co/investors/profile/99fund) — VC Fund, 1 deal together
- [Baoshan State Investment Group](https://shizune.co/investors/profile/baoshan-state-investment-group) — VC Fund, 1 deal together
- [Beijing Shunyuan Changxin Consulting Management](https://shizune.co/investors/profile/beijing-shunyuan-changxin-consulting-management) — VC Fund, 1 deal together
- [Cathay Capital](https://shizune.co/investors/profile/cathaycapital) — VC Fund, 1 deal together

## Similar investors

### Similar industry
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [ARCH Venture Partners](https://shizune.co/investors/profile/arch-venture-partners) — VC Fund
- [OrbiMed](https://shizune.co/investors/profile/orbimed-advisors) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

### Similar country
- [National Development Fund of Taiwan Government](https://shizune.co/investors/profile/national-development-fund-of-taiwan-government) — VC Fund
- [Darwin Venture Management](https://shizune.co/investors/profile/darwin-venture-management) — VC Fund
- [AVA Angels](https://shizune.co/investors/profile/ava-angels) — VC Fund

## Featured in investor lists
- [Biotechnology Investors in Taiwan](https://shizune.co/investors/biotechnology-investors-taiwan)
- [Health Care VC Funds in Taiwan](https://shizune.co/investors/health-care-vc-funds-taiwan)
- [Biotech Investors in Taiwan](https://shizune.co/investors/biotech-investors-taiwan)
- [Biotechnology VC Funds in Taiwan](https://shizune.co/investors/biotechnology-vc-funds-taiwan)
- [Biotech VC Funds in Taiwan](https://shizune.co/investors/biotech-vc-funds-taiwan)

## FAQ

### What does Center Ventures invest in?

Center Ventures invests primarily in Biotechnology, Pharmaceutical and Medical startups, most often at Series A and Series B stage. Most of the 7 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is Center Ventures's check size?

Center Ventures typically joins rounds of $24M–$62M at Series A and $100M–$102M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Center Ventures participates in.

### When did Center Ventures last invest?

The most recent investment recorded for Center Ventures closed in Mar 2025. Shizune tracks 7 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co